Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CStone to Build Global R&D Headquarters in Suzhou | Contract Pharma

What are you searching for?

Sign in
Breaking News

CStone to Build Global R&D Headquarters in Suzhou

Aims to enhance the company's capabilities and efficiency in R&D and the potential for future collaborations

By: Cassandra Gervolino

The signing ceremony for CStone Pharmaceuticals‘ Global R&D Headquarters and Industrialization Base took place in Suzhou on August 6. The event marks the building of another state-of-the-art research and development (R&D) center and manufacturing facility in Suzhou. 
 
According to the agreement, the construction of the site, with a planned building area of approximately 100,000m2, will be commissioned to a third party and is scheduled to break ground in 2020. Once completed, the complex will be equipped with integrated capabilities for R&D, Pilot Plant, and full commercial scale manufacturing, which will have a production capacity of 26,000L for macromolecule biologics and 1 billion tablets and capsules for small molecule drugs.
 
“The Suzhou Industrial Park has in recent years created a vibrant innovation-driven biopharmaceutical ecosystem through its effective promotion of emerging strategic industries. Since its inception in 2016, CStone has received tremendous support from the Suzhou Industrial Park. We are highly confident in SIP’s policy environment and infrastructure, and have therefore chosen Suzhou as our global headquarters for R&D and manufacturing. With a strong base in Suzhou, CStone aims to become globally recognized as a leading biopharmaceutical company in China and make significant contributions to the sector in Suzhou and nationwide,” said Dr. Frank Jiang, Chairman and CEO of CStone.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics